2B or Not 2B? That Was the Question for Aspartame In our recent Carrier Management article, titled “2B or Not 2B? That Was the Question for Aspartame,” we delve into…
read morePraedicat Posts on Carrier Management
August 30, 2023: D&O Underwriters May Be Worried About the Wrong Greenhouse Gas Greenwashing lawsuits with respect to climate change, while still relatively uncommon, have seen an uptick in recent…
read moreJune 8, 2023: Endocrine Disruption Litigation Has Arrived In their latest article for Carrier Management, Praedicat’s David Loughran and Adam Grossman explore the emergence of endocrine disruption as a major…
read moreFebruary 28, 2023: Risk in the News – Ultraprocessed Foods Ultraprocessed foods are ready-to-consume, hyper-palatable, low-cost, and, according to critics, designed to replace all other food groups. But are they…
read moreMarch 9th, 2022: Casualty Underwriting: The Original ESG In their latest article with Carrier Management, David Loughran and Robert Reville examine a topic that is top of mind for investors,…
read moreNovember 24th, 2021: What Do You Do With Emerging Interest Risks? What’s interesting to scientists should always be of interest to liability insurers. That’s the message our own Dr. Adam…
read moreAugust 24th, 2021: PFAS Litigation Levels Already at Epic Proportions PFAS litigation has reached epic proportions. Praedicat recently completed a massive data collection for our PFAS Litigation Tracker, a tool…
read moreMay 25th, 2021: Opioids Are the Next Tobacco. Are Antibiotics the Next Opioids? In our most recent Carrier Management article, Praedicat’s Senior Scientist and VP of Modeling, Dr. Adam Grossman and…
read moreApril 5th, 2021: In the latest Carrier Management article, Pandemic Risk: Finding the Opportunity in Liability, Adam Grossman, VP of Modeling and Senior Scientist at Praedicat, and Nita Madhav, CEO…
read moreFebruary 22, 2021: In the Carrier Management article, Emerging Damage: The Case of Melamine, our CEO Dr. Robert Reville, Senior Scientist and VP of Modeling, Dr. Adam Grossman and Senior…
read moreSeptember 28th, 2020: In the Reuters article, ‘Take Home’ Lawsuits Over COVID Infections Could be Costly for U.S. Employers, Praedicat CEO Robert Reville provides results from Praedicat’s suite of take-home COVID-19 scenarios. The Reuters’ article cites…
read morePraedicat Featured in new Carrier Management video series, ExecTalk As part of Carrier Management’s new video series, ExecTalk, Praedicat’s Bob Reville and Adam Grossman give a glimpse of the 9…
read more- 1
- 2